Detalles de la búsqueda
1.
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Lancet Oncol
; 25(3): e126-e135, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38423058
2.
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
Cancer Immunol Immunother
; 72(3): 759-767, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976415
3.
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 573-586, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203067
4.
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
BMC Cancer
; 23(1): 648, 2023 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434119
5.
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Int J Cancer
; 148(2): 385-395, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32965028
6.
The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis.
Gynecol Oncol
; 163(2): 433-444, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253390
7.
Validation of the updated renal graded prognostic assessment (GPA) for patients with renal cancer brain metastases treated with gamma knife radiosurgery.
J Neurooncol
; 153(3): 527-536, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170460
8.
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer.
Future Oncol
; 16(19): 1371-1384, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469606
9.
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
Br J Cancer
; 128(5): 707-710, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564561
10.
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
Ann Surg Oncol
; 30(1): 587-588, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319872
11.
Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences.
Value Health
; 20(4): 627-636, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408005
12.
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel.
Int J Cancer
; 136(6): E760-72, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25242736
13.
Bronchiolitis after Combination Immunotherapy With Ipilimumab and Nivolumab in a Melanoma Patient.
J Immunother
; 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38409751
14.
Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.
Heliyon
; 10(1): e23170, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38187310
15.
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
Nat Commun
; 15(1): 1349, 2024 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355607
16.
Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol.
Clin Cancer Res
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630551
17.
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Sci Rep
; 14(1): 11244, 2024 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38755213
18.
[Promosing cancer drug, but not available; the complexity of alternative access procedures].
Ned Tijdschr Geneeskd
; 1672023 11 22.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-37994735
19.
Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry.
Prostate Cancer Prostatic Dis
; 26(1): 162-169, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36224377
20.
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
Eur J Cancer
; 185: 167-177, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996627